Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nora Bayani

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Breast Cancer Research : BCR|February 11, 2017
Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancerZhi Hu, Jian-Hua Mao, Christina Curtis, et al.
Cancer Research|January 17, 2009
Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibitionOlga K Mirzoeva, Debopriya Das, Laura M Heiser, et al.
Breast Cancer Research : BCR|July 3, 2016
Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancerZhi Hu, Jian-Hua Mao, Christina Curtis, et al.
Cancer Cell|December 13, 2006
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesRichard M Neve, Koei Chin, Jane Fridlyand, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2011
Subtype and pathway specific responses to anticancer compounds in breast cancerLaura M Heiser, Anguraj Sadanandam, Wen-Lin Kuo, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Breast Cancer Research : BCR|February 11, 2017
Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancerZhi Hu, Jian-Hua Mao, Christina Curtis, et al.
Cancer Research|January 17, 2009
Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibitionOlga K Mirzoeva, Debopriya Das, Laura M Heiser, et al.
Breast Cancer Research : BCR|July 3, 2016
Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancerZhi Hu, Jian-Hua Mao, Christina Curtis, et al.
Cancer Cell|December 13, 2006
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesRichard M Neve, Koei Chin, Jane Fridlyand, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2011
Subtype and pathway specific responses to anticancer compounds in breast cancerLaura M Heiser, Anguraj Sadanandam, Wen-Lin Kuo, et al.
Pageof 2